COVID-19: a patient with cardiovascular disease at high risk
The COVID-19 pandemic that has swept the planet has posed many questions for doctors around the world, including the tactics of managing patients with cardiovascular disease, both infected and self-isolated. A symposium held with the support of the Merck company was devoted to this problem: "CO...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | article |
| Lenguaje: | RU |
| Publicado: |
IP Morozov P.V.
2020
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/9b61330ead8d495d8c880a3caf622542 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:9b61330ead8d495d8c880a3caf622542 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:9b61330ead8d495d8c880a3caf6225422021-11-30T16:09:16ZCOVID-19: a patient with cardiovascular disease at high risk2075-082X2542-218910.26442/2075082X.2020.2.200231https://doaj.org/article/9b61330ead8d495d8c880a3caf6225422020-09-01T00:00:00Zhttps://syst-hypertension.ru/2075-082X/article/viewFile/42264/pdfhttps://doaj.org/toc/2075-082Xhttps://doaj.org/toc/2542-2189The COVID-19 pandemic that has swept the planet has posed many questions for doctors around the world, including the tactics of managing patients with cardiovascular disease, both infected and self-isolated. A symposium held with the support of the Merck company was devoted to this problem: "COVID-19: a patient with cardiovascular pathology at a particular risk".Irina E. ChazovaY V ZhernakovaOlga D. OstroumovaIP Morozov P.V.articleDiseases of the circulatory (Cardiovascular) systemRC666-701RUСистемные гипертензии, Vol 17, Iss 2, Pp 76-83 (2020) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
RU |
| topic |
Diseases of the circulatory (Cardiovascular) system RC666-701 |
| spellingShingle |
Diseases of the circulatory (Cardiovascular) system RC666-701 Irina E. Chazova Y V Zhernakova Olga D. Ostroumova COVID-19: a patient with cardiovascular disease at high risk |
| description |
The COVID-19 pandemic that has swept the planet has posed many questions for doctors around the world, including the tactics of managing patients with cardiovascular disease, both infected and self-isolated. A symposium held with the support of the Merck company was devoted to this problem: "COVID-19: a patient with cardiovascular pathology at a particular risk". |
| format |
article |
| author |
Irina E. Chazova Y V Zhernakova Olga D. Ostroumova |
| author_facet |
Irina E. Chazova Y V Zhernakova Olga D. Ostroumova |
| author_sort |
Irina E. Chazova |
| title |
COVID-19: a patient with cardiovascular disease at high risk |
| title_short |
COVID-19: a patient with cardiovascular disease at high risk |
| title_full |
COVID-19: a patient with cardiovascular disease at high risk |
| title_fullStr |
COVID-19: a patient with cardiovascular disease at high risk |
| title_full_unstemmed |
COVID-19: a patient with cardiovascular disease at high risk |
| title_sort |
covid-19: a patient with cardiovascular disease at high risk |
| publisher |
IP Morozov P.V. |
| publishDate |
2020 |
| url |
https://doaj.org/article/9b61330ead8d495d8c880a3caf622542 |
| work_keys_str_mv |
AT irinaechazova covid19apatientwithcardiovasculardiseaseathighrisk AT yvzhernakova covid19apatientwithcardiovasculardiseaseathighrisk AT olgadostroumova covid19apatientwithcardiovasculardiseaseathighrisk |
| _version_ |
1718406460556181504 |